Bain Capital Public Equity Management, LLC - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 60 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 20.98 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bain Capital Public Equity Management, LLC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q1 2019$292,000
-84.6%
231,418
-42.1%
0.03%
-79.7%
Q1 2018$1,900,000
-80.3%
399,947
-75.9%
0.14%
-60.6%
Q4 2017$9,666,000
+1148.8%
1,657,832
+349.8%
0.35%
+614.3%
Q3 2017$774,000
-37.2%
368,590
+39.9%
0.05%
-33.8%
Q2 2017$1,233,000263,4980.07%
Other shareholders

There were no reported owners of PROTEOSTASIS THERAPEUTICS IN in Q2 2019.

NameSharesValueWeighting ↓
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders